Xenetic Biosciences (XBIO) Payables (2011 - 2026)
Xenetic Biosciences' Payables was $572,440 in Q2 2026, up 2.8% from $556,602 a year earlier and up 2.4% from the prior quarter.
Powered by 
Analysis
Xenetic Biosciences (XBIO) Payables (2011 - 2026) Analysis & Trends
At the end of FY2025, Payables at Xenetic Biosciences came in at $709,916, up 16.3% from FY2024.
- Payables shows a five-year compound annual growth rate of 3.1% (FY2020 to FY2025).
- In earlier years, Payables was $610,648 in FY2024 (+7.4%), $568,753 in FY2023 (-27.6%), $785,796 in FY2022 (-25.8%) and $1.06 million in FY2021 (+73.7%).
- Quarterly Payables has moved between $248,485 (Q3 2021) and $1.3 million (Q2 2024) over five years.
- Compared with a year earlier, Payables has increased for three straight quarters, with an average decline of 2.1% over the last eight quarters.
- The best year-over-year quarter for Payables over five years was Q1 2022 (growth of 276.6%); the worst was Q2 2025 (a decline of 57.3%).
- Per Business Quant data, XBIO's Payables in the three quarters before Q2 2026 was $558,808 (Q1 2026), $709,916 (Q4 2025) and $578,250 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Xenetic Biosciences | 5.46 Mn | -20.36 Mn | - | 572,440.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 572,440.00 |
| Mar 31, 2026 | 558,808.00 |
| Dec 31, 2025 | 709,916.00 |
| Sep 30, 2025 | 578,250.00 |
| Jun 30, 2025 | 556,602.00 |
| Mar 31, 2025 | 427,634.00 |
| Dec 31, 2024 | 610,648.00 |
| Sep 30, 2024 | 766,064.00 |
| Jun 30, 2024 | 1.30 Mn |
| Mar 31, 2024 | 506,011.00 |
| Dec 31, 2023 | 568,753.00 |
| Sep 30, 2023 | 619,939.00 |
| Jun 30, 2023 | 650,034.00 |
| Mar 31, 2023 | 597,185.00 |
| Dec 31, 2022 | 785,796.00 |
| Sep 30, 2022 | 848,080.00 |
| Jun 30, 2022 | 806,484.00 |
| Mar 31, 2022 | 782,588.00 |
| Dec 31, 2021 | 1.06 Mn |
| Sep 30, 2021 | 248,485.00 |
API Access
Xenetic Biosciences Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=XBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "XBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=XBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();